Werner Creutzfeldt | Academic Influence

Werner Creutzfeldt's AcademicInfluence.com Rankings

Werner Creutzfeldt

Philosophy

#2579

World Rank

#4365

Historical Rank

Logic

#1200

World Rank

#1891

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Werner Creutzfeldt's Degrees

Doctorate Medicine University of Göttingen
PhD Medicine University of Göttingen

Why Is Werner Creutzfeldt Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Werner Otto Carl Creutzfeldt was a German professor of internal medicine and an expert in gastrointestinal endocrinology. Biography Creutzfeldt was born in Berlin and raised in Kiel. During the Second World War, he served in the German Navy from 1942 to 1945. He studied philosophy at the University of Freiburg before completing an MD at the University of Kiel's Institute of Anatomy in 1950.

(See a Problem?)

Werner Creutzfeldt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. (1993) (1535)
Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes (2006) (1211)
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients (1993) (919)
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. (1986) (821)
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. (1996) (497)
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. (1993) (484)
Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. (1997) (443)
The incretin concept today (1979) (436)
[The natural course of chronic pancreatitis--pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease]. (1995) (382)
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. (1996) (353)
Histopathological classification of nonantral gastric endocrine growths in man. (1988) (346)
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. (1993) (330)
Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I diabetic patients (1996) (326)
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7–36 amide]) in patients with NIDDM (1996) (293)
Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. (1989) (241)
Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets (1985) (221)
Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. (1987) (207)
Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. (1987) (194)
Gut hormones and diabetes mellitus. (1992) (184)
Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). (1975) (182)
Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). (1995) (177)
The achlorhydria-carcinoid sequence: role of gastrin. (1988) (170)
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? (1984) (169)
Long-term omeprazole treatment in man: effects on gastric endocrine cell populations. (1988) (151)
New developments in the incretin concept (1985) (150)
Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. (1974) (142)
Gastrointestinal somatostatin: extraction and radioimmunoassay in different species. (1978) (136)
Exocrine pancreatic function in insulin-dependent diabetes mellitus. (1982) (136)
Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels (1978) (126)
The entero-insular axis in type 2 diabetes--incretins as therapeutic agents. (2001) (123)
Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. (1993) (122)
Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. (1988) (116)
The possible role of phospholipase A in the pathogenesis of acute pancreatitis. (1969) (115)
Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. (1982) (115)
The Course of Pain Is the Same in Alcohol‐ and Nonalcohol‐Induced Chronic Pancreatitis (1995) (112)
Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. (1979) (112)
Mucosal gastrin concentration, molecular forms of gastrin, number and ultrastructure of G-cells in patients with duodenal ulcer. (1976) (110)
Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. (1989) (107)
Aetiology and pathogenesis of pancreatitis. (Current concepts). (1970) (106)
Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose (1976) (106)
Carcinoids and carcinoid syndrome. (1987) (105)
Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase (1987) (102)
Carcinoid Tumors: Development of Our Knowledge (1996) (98)
[Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)]. (1975) (98)
Functional reserve capacity of the exocrine pancreas. (1986) (96)
Influence of gastric inhibitory polypeptide antiserum on glucose-induced insulin secretion in rats. (1982) (96)
Gastric inhibitory polypeptide. (1980) (95)
The [pre-] history of the incretin concept (2005) (93)
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. (1991) (92)
Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution (1980) (92)
Gastrointestinal peptides and insulin secretion. (1987) (91)
Secretin‐Pancreozymin Test (SPT) and Endoscopic Retrograde Cholangiopancreatography (ERCP): Both Are Necessary for Diagnosing or Excluding Chronic Pancreatitis (1996) (89)
Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. (1986) (87)
Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats. (1991) (83)
Morbidity and mortality in 602 patients with acute pancreatitis seen between the years 1980-1994. (1996) (81)
Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. (1987) (81)
Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7–36 amide] in the fasting state in healthy subjects (1995) (78)
Somatostatin and the stomach: exocrine and endocrine aspects. (1978) (76)
Somatostatin therapy of acute experimental pancreatitis. (1977) (75)
Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats. (1992) (74)
The influence of glucagon on acute experimental pancreatitis in the rat. (1974) (73)
Liver diseases and diabetes mellitus. (1970) (72)
Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption (1983) (72)
[Endocrine tumors of the pancreas]. (1979) (71)
Session 6: Is Hypergastrinaemia Dangerous to Man? (1991) (69)
Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide. (1991) (69)
Circadian serum gastrin concentrations in control persons and in patients with ulcer disease. (1972) (67)
PACAP is a stimulator of neurogenic contraction in guinea pig ileum. (1993) (67)
Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. (1988) (66)
Pancreatic duct cells in rats: secretory studies in response to secretin, cholecystokinin-pancreozymin, and gastrin in vivo. (1977) (65)
Effect of 1-desoxynojirimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro. (1985) (65)
Inhibition of intraduodenal trypsin does not stimulate exocrine pancreatic secretion in man. (1983) (59)
Plasma cholecystokinin levels in patients with chronic pancreatitis. (1985) (58)
[INSULIN SECRETION IN VITRO. I. INHIBITION OF GLUCOSE-INDUCED INSULIN RELEASE BY INSULIN]. (1965) (58)
Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance (1979) (57)
Treatment of Gastrointestinal Endocrine Tumours with Interferon-α and Octreotide (1991) (56)
Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells. (1993) (56)
Effect of gastrointestinal hormones on insulin and glucagon secretion. (1970) (56)
Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? (1986) (54)
Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. (1989) (54)
Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion. (1984) (53)
Biochemical and morphological investigations of 30 human insulinomas (1973) (53)
Inhibition of gastric secretion by calcitonin in man. (1971) (53)
Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. (1988) (53)
Tenth Annual Meeting of the European Association for the Study of Diabetes (1974) (53)
Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects. (1992) (52)
The morphological substrate of the inhibition of insulin secretion by diazoxide. (1969) (52)
Inhibition of Gastric Inhibitory Polypeptide (GIP) Release by Insulin and Glucose in Juvenile Diabetes (1980) (51)
Etiology and incidence of acute pancreatitis: a 20-year study in a single institution. (1989) (51)
Somatostatin and insulin release from isolated rat pancreatic islets in response to D-glucose, l-leucine, alpha-ketoisocaproic acid or D-glyceraldehyde: evidence for a regulatory role of adenosine-3' ,5'-cyclic monophosphate. (1977) (51)
Analysis of the inhibitory effect of biguanides on glucose absorption: Inhibition of active sugar transport (1971) (50)
Mechanism of insulin resistance in CCl4-induced cirrhosis of rats. (1992) (50)
Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush. (1987) (50)
Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours (1986) (49)
Comparison of Different Methods for the Evaluation of the Oral Glucose Tolerance Test (1970) (49)
Pituitary adenylate cyclase-activating peptide is a potent modulator of human colonic motility. (1993) (47)
Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. (1994) (46)
Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content (1985) (46)
[Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies]. (1956) (45)
Effect of somatostatin on basal and stimulated pancreatic secretion in the rat. (1978) (45)
Polyamine Concentrations in Pancreatic Tissue, Serum, and Urine of Patients with Pancreatic Cancer (1990) (44)
Disturbances of the entero-insular axis. (1983) (44)
Incretins and their analogues as new antidiabetic drugs. (2003) (43)
Commercially available preparations of porcine glucose-dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP-fragment and cholecystokinin-33/-39. (1987) (43)
A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome (2003) (42)
In Vitro Studies of the Rate of Proinsulin and Insulin Turnover in Seven Human Insulinomas (1973) (41)
Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. (2005) (41)
Appearance of gastrin and somatostatin in the human fetal stomach, duodenum and pancreas. (1979) (41)
Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. (1990) (40)
Comparison of the effect of GIP and GLP‐1 (7–36amide) on insulin release from rat pancreatic islets (1992) (40)
Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain. (1991) (39)
Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release. (1978) (39)
Effects of gastrointestinal hormones and carbamylcholine on cAMP accumulation in isolated pancreatic duct fragments from the rat. (1980) (39)
Is hypergastrinaemia dangerous to man? (1991) (39)
[Intravenous injections of glucose, insulin and tolbutamide in healthy persons, diabetics, cirrhotics, and patients with insuloma (together with a contribution on the diagnostic value of the tolbutamide tests)]. (1962) (38)
Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus. (1988) (38)
Critical evaluation of the 'heated-hand-technique' for obtaining 'arterialized' venous blood: incomplete arterialization and alterations in glucagon responses. (1992) (38)
Historical background and natural history of carcinoids. (1994) (38)
Short-Term Administration of the Somatostatin Analogue SMS 201-995 in Patients with Carcinoid Tumours (1986) (36)
[Results of operative treatment of chronic pancreatitis, especially exocrine and endocrine functions (author's transl)]. (1975) (36)
Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation (2004) (36)
Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro‐entero‐pancreatic hormones in man Feedback control of cholecystokinin and gastrin secretion (1991) (36)
Pancreatic endocrine tumors--the riddle or their origin and hormone secretion. (1975) (35)
Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. (1981) (35)
Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole. (1989) (34)
Adrenergic and cholinergic interactions in rat gastric somatostatin and gastrin release. (1982) (34)
10 Hypoglycaemia. 1. Insulin secreting tumours (1976) (33)
[Australia (SH) antigen findings in patients with liver diseases and blood donors]. (1970) (33)
Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells. (1990) (33)
Adaptation of the pancreas during treatment with enzyme inhibitors in rats and man. (1985) (33)
Adrenergic control of rat gastric somatostatin and gastrin release. (1983) (33)
Metabolic actions of insulin‐like growth factor‐I in cultured hepatocytes from adult rats (1990) (32)
CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides (1989) (32)
Galanin inhibits glucose-induced insulin release in vitro. (1989) (31)
Increase of intestinal brush border hydrolases in mucosa of streptozotocin-diabetic rats (1972) (31)
Decreased GIP Secretion through Impairment of Absorption1 (1980) (31)
Serotonin Release Into Blood After Food and Pentagastrin Studies in Healthy Subjects and in Patients With Metastatic Carcinoid Tumors (1986) (31)
Identification of the C-terminally alpha-amidated amino acid in peptides by high-performance liquid chromatography. (1987) (30)
Entero-insular axis and diabetes mellitus. (1992) (30)
Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis. (1987) (30)
Influence of exocrine and endocrine pancreatic function on intestinal brush border enaymatic activities. (1975) (30)
[Inhibition of pentagastrin-induced gastric-acid secretion by somatostatin in man (author's transl)]. (1975) (30)
Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature. (1984) (29)
Endocrine tumors of the pancreas: clinical, chemical and morphological findings. (1980) (29)
Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats (1984) (29)
Acarbose for the Treatment of Diabetes Mellitus (1988) (28)
[Studies on frequency and course of icteric and anicteric transfusion hepatitis]. (1966) (28)
Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells (1995) (28)
Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients. (1985) (27)
Galanin: structural requirements for binding and signal transduction in RINm5F insulinoma cells. (1990) (27)
Long-Term Treatment of Patients with Endocrine Gastrointestinal Tumours with the Somatostatin Analogue SMS 201-995 (1986) (27)
Calciphylactic pancreatitis and pancreatitis in hyperparathyroidism. (1970) (26)
Role of GIP and insulin in glucose-induced changes in intestinal motility patterns. (1987) (26)
[Follow-up and diagnostic procedure in chronically recurrent and chronic pancreatitis]. (1970) (26)
Gastric inhibitory polypeptide: Effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro (1975) (26)
Pancreastatin--a novel regulatory peptide? (1991) (26)
Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats. (1989) (26)
Adaptive responses to pharmacological inhibition of small intestinal alpha-glucosidases in the rat. (1987) (25)
Effect of food deprivation on rat gastric somatostatin and gastrin release. (1982) (25)
Effects of the α‐glucosidase inhibitor acarbose on the development of long‐term complications in diabetic animals: pathophysiological and therapeutic implications (1999) (25)
[Observations on four patients with total duodenopancreatectomy in carcinoma of the pancreas]. (1959) (25)
Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide. (1991) (24)
Risk-Benefit Assessment of Omeprazole in the Treatment of Gastrointestinal Disorders (1994) (24)
Insulinomas: Clinical Presentation, Diagnosis, and Advances in Management (1994) (24)
[The behavior of leucine aminopeptidase and other enzymes in the blood serum in liver, biliary and pancreatic diseases]. (1960) (24)
Vasoactive intestinal polypeptide induces neurogenic contraction of guinea-pig ileum. Involvement of acetylcholine and substance P (1992) (23)
Gastric inhibitory polypeptide (GIP), gastrin and insulin: Response to test meal in coeliac disease and after duodeno-pancreatectomy (1976) (23)
THE EFFECT OF DIFFERENT SOLUTIONS FOR ORGAN PRESERVATION ON IMMEDIATE POSTISCHEMIC PANCREATIC FUNCTION IN VITRO (1993) (23)
Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models (1992) (23)
Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth. (1992) (23)
LOWERING OF BASAL AND STIMULATED SERUM IMMUNOREACTIVE GASTRIN AND GASTRIC SECRETION IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME BY SOMATOSTATIN (1975) (22)
Experimental and clinical pharmacology (2008) (22)
Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy. (1989) (22)
Elevated plasma cholecystokinin concentrations in exocrine pancreatic atrophy in the rat. (1984) (22)
Origin, chemistry, physiology and pathophysiology of the gastrointestinal hormones : International Symposium Wiesbaden October 24 and 25, 1969 (1970) (22)
[Concomitance of pancreatitis and hyperparathyroidism. Practical and theoretical implications]. (1963) (22)
Histochemistry, ultrastructure and hormone content of human insulinomas. (1976) (22)
Statement on Postprandial Hypoglycemia (1988) (21)
Some Phylogenetic Aspects on the Enteroinsular Axis with Particular Regard to the Appearance of the Gastric Inhibitory Polypeptide1 (1980) (20)
Role of gastrointestinal transit in the delay of absorption by viscous fibre (guar). (1984) (20)
Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist. (1992) (20)
Ground-glass hepatocytes in unselected liver biopsies. ultrastructure and relationship to hepatitis B surface antigen. (1976) (20)
[Influence of ovulation inhibitors on clinicochemical norms]. (1969) (20)
Dynamics of somatostatin release from isolated rat pancreatic islets (1977) (20)
Effect of synthetic and natural secretin on the function of the exocrine pancreas in man. (1981) (20)
Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver (1986) (20)
Pituitary adenylate cyclase activating peptide, a novel VIP-like gut-brain peptide, relaxes the guinea-pig taenia caeci via apamin-sensitive potassium channels (1992) (20)
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor (1988) (19)
Calcitonin Gene-Related Peptide (CGRP) modulates cholinergic neurotransmission in the small intestine of man, pig and guinea-pig via presynaptic CGRP receptors (1991) (19)
EVIDENCE FOR DIFFERENT MODES OF INSULIN SECRETION (1970) (19)
[Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide]. (1966) (19)
[The influence of coffee and caffeine on gastrin and acid secretion in man (author's transl)]. (1976) (19)
Diabetes Mellitus: Pathophysiology and Therapy (1989) (19)
Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the alpha-glucosidase inhibitor miglitol. (1990) (19)
Influence of secretin on the course of acute experimental pancreatitis in rats. (1983) (19)
In vivo metabolic action of insulin-like growth factor I in adult rats (1991) (18)
Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. (1984) (18)
Insulinotropic factors of the gut--the broadening incretin concept. (1980) (18)
Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients (1990) (18)
[Calcitonin-induced inhibition of exocrine pancreatic secretion in man]. (1971) (18)
Effect of cimetidine on lower esophageal sphincter pressure, intragastric pH and serum levels of immunoreactive gastrin in man. (1977) (18)
Betazole-induced GIP secretion is not mediated by gastric HCl. (1982) (17)
Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding. (1985) (17)
Adrenergic modulation of gastric somatostatin release in rats (1980) (17)
Gastrointestinal somatostatin in man and dog. (1978) (17)
Neuropeptide K-(1–24)-peptide: Storage and release by carcinoid tumors (1988) (17)
[Enzymatic experiments on the mechanism of action of hypoglycemic drugs]. (1957) (17)
Long-term omeprazole therapy in peptic ulcer disease (1993) (17)
Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour (1985) (17)
[The effect of insulin on the metabolism of isolated perfused livers of normal and alloxan-diabetic rats. I. The metabolism of isolated perfused livers in normal and alloxan-diabetic rats under various experimental conditions]. (1966) (17)
Inhibition of bile salt absorption by blood-sugar lowering biguanides (1975) (17)
A hyperinsulinaemic, sequentially eu‐ and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma (1997) (17)
Response of gastric inhibitory polypeptide (GIF) to test meal in chronic pancreatitis — Relationship to endocrine and exocrine insufficiency (1976) (17)
Budd-Chiari syndrome as the primary manifestation of a fibrolamellar hepatocellular carcinoma. (1992) (17)
Insulinsekretion in vitro (1965) (17)
Effect of Dietary Fiber on Absorption and Motility (1980) (16)
Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis. (1990) (16)
The antrat gastrin-producing G-cell: Biochemical and ultrastructural responses to feeding (1978) (16)
The perfused porcine pancreas as a model for testing organ protective solutions (1989) (16)
Post-translational processing of preprotachykinins. Isolation of protachykinin-(1-37)-peptide from human adrenal-medullary phaeochromocytoma tissue. (1988) (16)
Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients. (2009) (16)
Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation (1992) (15)
Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. (1986) (15)
Intensive medical treatment of severe acute pancreatitis (1981) (15)
Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon. (1977) (15)
Role of Circulating Gastrin in Colorectal Adenomas and Carcinomas (1999) (15)
Gastrointestinal peptides--rôle in pathophysiology and disease. (1982) (15)
HYPERSECRETION OF PROINSULIN DOES NOT EXPLAIN THE HYPERINSULINAEMIA OF PATIENTS WITH LIVER CIRRHOSIS (1986) (15)
Somatostatin and gastrin release into the gastric lumen in rats. (1981) (15)
Hepatic artery embolization for treatment of endocrine gastrointestinal tumors with liver metastases. (1984) (15)
Preceding Hyperinsulinemia Prevents Demonstration of Insulin Effect on Fat-induced Gastric Inhibitory Polypeptide (GIP) (1984) (15)
Contribution to the Pathogenesis of Tumour Hypoglycaemia (1970) (15)
Enzymatic and ultrastructural development of the bovine exocrine pancreas. (1972) (15)
Influence of short- and long-term feeding of an alpha-amylase inhibitor (BAY e 4609) on the exocrine pancreas of the rat. (1981) (15)
The effect of experimental cholestasis on the negative feedback regulation of cholesterol synthesis in rat liver. (1970) (15)
The combined use of insulin, tolbutamide and biguanides in the treatment of diabetes mellitus. Clinical significance and experimental findings. (1963) (15)
Somatostatin and gastrin release from canine stomach. (1980) (14)
Antral Helicobacter pylori-like organisms in different states of gastric acid secretion. (1991) (14)
Alpha Cell Cytotoxins: Their Influence on Carbohydrate Metabolism and the Effect of the Oral Blood Glucose Reducing Sulfonamides on the Islet Cells (1957) (14)
The consequences of hypergastrinemia. (1994) (14)
Dynamics of somatostatin and insulin release from isolated rat pancreatic islets: evidence for intraislet interactions between B cells and D cells. (1978) (14)
Ornithine decarboxylase and polyamines in cholecystokinin‐induced pancreatic growth in rats: effects of α‐difluoromethylornithine and the CCK receptor antagonist L‐364,718 (1989) (14)
[Comparative studies with the hypoglycemic guanidine derivatives, Synthalin B and phenylethyldiguanide (DBI); a contribution to the problem of so-called A cell poison]. (1958) (14)
Sponsored congress attendance--does it happen, does it matter? (2000) (14)
Trophic effect of truncal vagotomy on the rat pancreas. (1986) (13)
Acid-induced gastric inhibitory polypeptide secretion in man. (1980) (13)
Pancreatic polypeptide and gastrin release during sham feeding in man. (1984) (13)
Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man. (1990) (13)
CORRELATION OF PLASMA LEVELS OF ORAL ANTIDIABETIC AGENTS WITH BLOOD SUGAR RESPONSES (1959) (13)
Inhibition of intestinal amino acid transport by blood sugar lowering biguanides (1973) (13)
First International Symposium on Acarbose : proceedings, effects on carbohydrate and fat metabolism, Montreux, October 8-10, 1981 (1982) (13)
Effect of Camostate Administration for Two Weeks on Experimental Pancreatitis in Mice and Rats (1993) (13)
Therapy of exocrine and endocrine pancreatic insufficiency. (1984) (13)
[STUDIES ON THE EFFECTS OF A TRYPSIN INHIBITOR (TRASYLOL) ON ENZYME ACTIVITIES AND MORPHOLOGY IN TAUROCHOLATE AND CALCIPHYLAXIS PANCREATITIS OF THE RAT (A CONTRIBUTION TO THE PATHOGENESIS OF PANCREATITIS. II.)]. (1965) (13)
Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II). (1991) (13)
Oral Treatment of Diabetes (1961) (12)
[Morphology, clinical features, diagnosis, and treatment of Zollinger-Ellison syndrome (author's transl)]. (1974) (12)
Inhibition of glycemic and hormonal responses after repetitive sucrose and starch loads by different doses of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in man. (1991) (12)
Glucose tolerance tests in 727 first-degree relatives of maturity-onset diabetics. (1969) (12)
Insulin release from isolated rat pancreatic islets induced by α-ketoisocaproic acid, L-leucine, D-glucose or D-glyceraldehyde: Effect of gastric inhibitory polypeptide or glucagon (1977) (12)
Hepatotrophic effects of pancreatic and gastrointestinal hormones in the rat in vivo and in vitro. (1977) (12)
Repeated upper gastrointestinal hemorrhage caused by metachromatic leukodystrophy of the gall bladder. (1992) (12)
Hypoglycaemia. 1. Insulin secreting tumours. (1976) (12)
CIRCULATING BRADYKININ‐LIKE IMMUNOREACTIVITY AND THE PENTAGASTRIN‐INDUCED CARCINOID FLUSH (1988) (12)
[Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin]. (1968) (12)
Influence of the CCK-antagonist loxiglumide on bile-induced experimental pancreatitis (1991) (11)
Specific monoclonal antibodies neutralize the action of PACAP 1–27 or PACAP 1–38 on intestinal muscle strips in vitro (1995) (11)
Impairment of stimulated insulin release from the isolated perfused rat pancreas by cyclosporine pretreatment. (1989) (11)
Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide. (1983) (11)
[Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas]. (1985) (11)
Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia (2007) (11)
The Incretin Concept (1988) (11)
Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man (1988) (11)
[Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. II. Free fatty acids, ketone bodies, triglycerides and cholesterol in blood]. (1968) (11)
Cyclosporine A in low doses induces functional and morphologic changes in rat pancreatic B cells. (1987) (11)
[The effect of insulin on the metabolism of isolated perfused liver of normal and alloxan-diabetic rats. II. Changes in metabolism under the influence of intraportal insulin infusions]. (1966) (10)
Evaluation of serum pancreatic polypeptide estimations following hormonal stimulation for the diagnosis of exocrine pancreatic insufficiency. (1984) (10)
[Inhibitors of insulin secretion]. (1968) (10)
Lack of hypoglycemic effect of bovine proinsulin in eviscerated, hepatectomized rats. (1969) (10)
Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation or food restriction (1978) (10)
Gastrointestinal hormones and insulin secretion. (1973) (10)
The reproducibility of the oral glucose tolerance test over long (5 years) and short periods (1 week) (1980) (10)
[Casuistical contributions to the effect of sulfonylurea in various special forms of diabetes mellitus: steroid diabetes, diabetes with hemochromatosis, renal diabetes & diabetes with a high insulin resistance]. (1957) (10)
Statement on “post-prandial” or “reactive” hypoglycaemia (1988) (9)
[Function of the exocrine pancreas in liver and biliary tract diseases studied with mecholyl ether tests]. (1956) (9)
Effect of low concentrations of glucagon on insulin release and cyclic AMP content in isolated rat islets. (1987) (9)
[Preoperative examinations in recurrent ulcer in the operated-on stomach]. (1977) (9)
The hepatic toxicity of obidoxim (Toxogonin) in man. (1970) (9)
Vascular basement membrane thickness in muscle of spiny mice and activities of glycolysis and gluconeogenesis in the liver of animals with spontaneous and experimental diabetes and of untreated human diabetics (1970) (9)
[Transfusion hepatitis and its prevention]. (1966) (9)
Effects of the alpha-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications. (1999) (9)
Urgent ERCP in all cases of acute biliary pancreatitis? A prospective randomized multicenter study. (1995) (9)
Valosin stimulates gastric and exocrine pancreatic secretion and inhibits fasting small intestinal myoelectric activity in the dog. (1987) (9)
[Factitious hypoglycemia caused by taking a sulfonylurea drug]. (2008) (9)
[Lipomatosis of the exocrine pancreas following D-penicillamine feeding of rats on choline deficiency diet]. (1973) (9)
[Clinical syndromes of hormonally active pancreatic tumors]. (1971) (8)
Preservation of the porcine pancreas with HTK and Euro‐Collins solution: studies in a reperfusion system (1990) (8)
[Effect of synthetic "thyreotropin releasing factor" on the plasma levels of thyreotropic hormone and growth hormone in healthy subjects, in patients with hyperthyreosis and primary hypothyreosis]. (1970) (8)
[The relationship between aetiological and promoting factors in the pathogenesis of diabetes mellitus in man and animals]. (1970) (8)
111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors. (1994) (8)
[Acupuncture to alleviate pain during colonoscopy]. (1991) (8)
The relationship between serum IRG levels and LES Pressure under various conditions. (1977) (8)
Influence of metronidazole on the breath hydrogen response and symptoms in acarbose-induced malabsorption of sucrose. (1982) (8)
Research society for study of diabetes in India (2005) (8)
Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose (1991) (8)
Hormone responsiveness of collagenase-isolated rat islets is markedly increased by short-term maintenance in tissue culture. (1988) (8)
[Hepatitis transmissions over a period of 10 years by a blood donor with posthepatitis liver cirrhosis]. (1962) (7)
Polyamines in human gastric and esophageal cancer. (1989) (7)
Serum-insulin levels in hypoglycaemic shock due to attempted suicide with tolbutamide and with insulin. (1969) (7)
In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat. (1990) (7)
Metabolic Effects of Gastric Inhibitory Polypeptide (1987) (7)
The effect of intravenous theophylline ethylenediamine on serum gastrin concentration in control subjects and patients with duodenal ulcers and Zollinger-Ellison syndrome. (1976) (7)
History of the European Pancreatic Club: The First 40 Years 1965–2005 (2005) (7)
[Studies on the prophylaxis of transfusion hepatitis with gamma globulin]. (1966) (7)
EFFECT OF EXOGENOUS INSULIN ON FASTING SERUM LEVELS OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) IN JUVENILE DIABETES (1981) (7)
Polyamines in human gastrointestinal malignancies. (1990) (7)
Effects of four orally administered analogues of prostaglandin E1 and E2 on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man (1989) (7)
Incidence and course of icteric and anicteric transfusion hepatitis. (1966) (7)
History of the European Pancreatic Club: The First 40 Years 1965–2005 (2005) (7)
[Current views on the mode of action of hypoglycemic sulfonamides]. (1969) (7)
Endocrine Pancreatic Function During Atrophy of the Exocrine Gland (1988) (7)
[Inhibition of intestinal absorption of sugars and amino acids by prenylamine (Segontin)]. (1972) (7)
Light and electron microscopical immunocytochemical localization of pancreastatin-like immunoreactivity in porcine tissues (2004) (6)
[The effect of a combination of N 1-Beta-phenylethylbiguanide (DBI, W 32) with insulin and tolbutamide on the metabolism of guinea pigs]. (1961) (6)
Safety of omeprazole (1994) (6)
[The effect of vagotomy on the gastrin level of serum, of antrum mucosa and of gastrin cells]. (1977) (6)
Effect of long-term fasting of obese patients on pancreatic exocrine function, gastrointestinal hormones and bicarbonate concentration in plasma. (1984) (6)
Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush (2004) (6)
[Serum insulin values in hypoglycemic shock during suicide attempts with tolbutamide and insuline]. (1968) (6)
[Physiologic and pharmacologic influence on insulin secretion]. (1971) (6)
Cirrhosis of the liver. On the aetiology, pathogenesis, results of treatment and period of survival in an unselected series of 560 patients. (1966) (6)
Evidence for Paracrine Function of Somatostatin (1987) (6)
[4-methylbenzenesulfonyl]-N'-butylurea (D 860) and insulin on the incorporation of C14-labelled carbon dioxide into liver glycogen]. (1960) (6)
Parotid saliva test in the diagnosis of chronic pancreatitis. (1979) (6)
Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-l-diabetic patients after successful combined pancreas and kidney transplantation (2004) (6)
Secretagogue response of azaserine-induced rat pancreatic acinar tumors in vivo. (1991) (6)
Increased somatostatin secretion from pancreatic islets of streptozotocin-diabetic rats in response to glucose (1980) (6)
Somatostatin cells in rat antral mucosa: qualitative and quantitative ultrastructural analyses in different states of gastric acid secretion (2004) (6)
Liver disease, insulin antagonism and diabetes mellitus. (1974) (6)
Approach to hepatic involvement by endocrine tumors of the gastrointestinal tract. (1988) (6)
Plasma digoxin concentrations during administration of dietary fibre (guar gum) in man. (1982) (6)
Trophic effect of protal blood in maintenance cultures of adult rat hepatocytes. (1981) (6)
Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach (2005) (5)
OBSERVATIONS ON THE TYPE AND ORIGIN OF THE HORMONE–PRODUCING CELLS IN THE ZOLLINGER–ELLISON AND VERNER-MORRISON SYNDROME (1970) (5)
Etiological and Promoting Factors in the Pathogenesis of Diabetes Mellitus (1976) (5)
Potent inhibition of insulin secretion from pancreatic islets by two novel neuropeptides, MMP-1 and MMP-2 (1989) (5)
The enteroinsular axis during treatment with glucosidase inhibitors (1987) (5)
Endocrine pancreatic function during atrophy of the exocrine gland. (1988) (5)
[Studies on therapeutic alteration of experimental liver cirrhosis in rats. III. Carbon tetrachloride cirrhosis in rats and its therapeutic alteration by gluco corticoids with and without simultaneous administration of antibiotics and androgens]. (1963) (5)
[Experimental studies on the effect of a kidney lesion on diabetes mellitus; alloxan diabetes and Masugi's kidney disease]. (1959) (5)
Consequences of gastric acid inhibition in man (1999) (5)
[Exocrine pancreatic function in chronic kidney failure]. (1968) (5)
[Exocrine and endocrine pancreas function following pancreatic trauma]. (1975) (5)
The Gastrin-Producing Cell (1974) (5)
[Abdominal pain caused by adhesions and their removal at laparoscopy (author's transl)]. (1976) (5)
INHIBITION OF GASTRIC SECRETION BY CALCITONIN (1971) (5)
[Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)]. (1988) (5)
Intestinal brush border enzyme activity in juvenile and maturity onset diabetes mellitus (1974) (5)
[Endocrine tumors of the gastrointestinal tract. Diagnosis and thereapy]. (1975) (5)
THE GASTROINTESTINAL EFFECTS OF CALCITONIN (1972) (5)
Immunohistologic investigations of human insulinomas (1972) (5)
[Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro]. (1984) (4)
Human insulinoma tissue: in vitro studies of proinsulin/insulin biosynthesis and release. (1976) (4)
[Erythema ab igne (livido reticularis e calore): a skin manifestation of chronic pancreatic diseases]. (1986) (4)
Influence of the HMG-CoA-reductase inhibitor lovastatin on cholesterol saturation index and nucleation time of duodenal bile. (1991) (4)
Controlled randomized multicenter trial of urgent endoscopic papillotomy for acute biliary pancreatitis (1995) (4)
Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments. (1988) (4)
Insulinsekretion in vitro (1965) (4)
[Adverse effect of oral antidiabetics: hypoglycemia]. (1973) (4)
Effect of three protective solutions on vascular resistance of the perfused porcine pancreas. (1990) (4)
The novel brain-gut peptide PACAP induces in vitro relaxation of the rat ileum (1992) (4)
[Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations]. (1988) (4)
[Chiral switch, a successful way for developing drugs: example of esomeprazole]. (2000) (4)
Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. (2001) (4)
The Changing Concept of the Enteroinsular Axis (1987) (4)
The effect of somatostatin on cellular proliferation (1994) (4)
Diabetes mellitus: A new look at diagnostic criteria (1979) (4)
[Bioptic diagnosis of obstructive jaundice and liver needle biopsy in biliary tract diseases]. (1954) (3)
Gastric inhibitory polypeptide and insulin response to increasing doses of oral glucose: dependency on glucose amount and volume of the test drink. (1986) (3)
Comparison of subcutaneously administered soluble insulin and des-(B26-B30)-insulin-B25-amide in rabbit, pig and healthy man. (1992) (3)
Inhibitory and immunological profile of therapeutic serum protein solutions (1983) (3)
[HYPOGLYCEMIA CAUSED BY LEUCINE]. (1965) (3)
[Function of the lower esophageal sphincter in the Zollinger-Ellison syndrome]. (1973) (3)
Luminar Secretion of Gastrointestinal Peptides : Release of Gastrin and Somatostatin into the Gastric Lumen in Rats (1980) (3)
Diltiazem inhibition of glucose-induced insulin secretion from the isolated perfused rat pancreas. (1988) (3)
[Increase of intestinal conjugated bile acid resorption in ileum of diabetic rats]. (1973) (3)
Lysosomal storage of glycogen as a sequel of α-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248) (1991) (3)
Befunde beim Antrumrest nach Billroth-II-Operation („excluded antrum“) — ein Beitrag zur Differentialdiagnose des Rezidivulcus mit Hypergastrinämie (1976) (3)
[Serum enzyme activities and bromsulphalein retention due to ovulation inhibitors]. (1968) (3)
Effect of secretin and VIP on isolated pancreatic duct fragments in vitro. (1980) (3)
[Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors]. (1971) (3)
[A comparison of percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography (author's transl)]. (1979) (3)
Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the α-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers (2004) (3)
Effect of selective proximal vagotomy (SPV) on serum concentration of GIP, insulin and gastrin in duodenal ulcer patients (DU) (1978) (3)
[Long-term treatment of Ménétrier disease with ranitidine]. (1989) (3)
Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers. (1984) (3)
[Effect of D-860 on alloxan diabetes in rabbits]. (1956) (3)
[Thrombolysis in the Budd-Chiari syndrome induced by partial thromboses of the inferior vena cava and the hepatic veins]. (1971) (3)
[Clinical relationships between diabetes mellitus and the liver]. (1959) (3)
Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine. (1973) (3)
Further evidence for an inhibition of hepatic gluconeogenesis in hypoglycemia due to non-insulin-productin tumors. (1969) (2)
Effect of Acid on GIP Secretion in Man1 (1980) (2)
Pancreatic transplantation or intensive insulin therapy? (1989) (2)
Dose-dependent inhibition by cyclosporine a of the induction of pancreatic ornithine decarboxylase (ODC) in rats (1989) (2)
Function and duties of an ethics committee at a university faculty of medicine: 13 years of personal experience. (1994) (2)
Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures (1989) (2)
[The effect of Nl, n-butylbiguanide (W37) and Nl, beta-phenylethylbiguanide (W32) on alloxan and phlorrhizin diabetes and intestinal glucose absorption in rats]. (1962) (2)
Is total gastrectomy still acceptable in the treatment of the Zollinger-Ellison syndrome? (2005) (2)
Serum enzyme activity and bromsulphalein retention during use of oral contraceptives. (1969) (2)
Introduction to a new Journal (1970) (2)
[Pathophysiology of the exocrine pancreas]. (1987) (2)
Characterization of the relaxant effect of PACAP and VIP on the taenia caeci of the guinea pig (1992) (2)
Incretin Effect in Normal and Type 2 Diabetic Subjects and Its Relation to the GIP Response (1987) (2)
[Letter: Hazards of infection in Australia antigen persistance]. (1974) (2)
[Studies on therapeutic alterability of experimental liver cirrhosis in rats. IV. Alteration of tetrachloride cirrhosis by liver extracts, lipocaic, sulfonamide derivatives and sulfhydryl compounds]. (1963) (2)
The use of gamma-globulin in the prophylaxis of transfusion hepatitis. (1967) (2)
[Frequency and prevention of transfusion hepatitis]. (1967) (2)
Influence of an absorbable alpha-glucosidase inhibitor (Bay o 1248) on the endocrine and exocrine pancreas of the rat. (1986) (2)
Insulin-dependent suppression of hepatic glucose output by GIP in the perfused rat liver (1983) (2)
Factitious hypoglycaemia. Its importance in the differential diagnosis of hyperinsulinism. (1969) (2)
[Different increase of serum gastrin during insulin hypoglycemia with and without aspiration of gastric juice]. (1973) (2)
[Calciphylaxis pancreatitis and pathogenesis of pancreatitis]. (1965) (2)
Electron-microscopical evidence for heterogeneity of micronodular argyrophil cell growth in man (1998) (2)
Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia (1990) (2)
Immunohistological, ultrastructural and biochemical investigations of human insulinomas. (1972) (2)
Cholecystokinin (CCK) inhibits gastric acid secretion in humans via a CCK-A receptor mediated mechanism (1992) (2)
The difference forms of immunoreactive gastrin in blood and tissue. (1974) (2)
Effects of copper on the exocrine pancreas. (1983) (2)
[Hypoglycemia factitia. A differential diagnostic significant form of hyperinsulinism]. (1969) (2)
[Comparison of quantitative liver function tests to clinical, laboratory chemical and biopsy findings in patients with liver diseases]. (1988) (2)
[Papillotomy in acute pancreatitis--more benefits than risks?]. (1992) (2)
Fat-induced secretion of gastric inhibitory polypeptide is coupled to chylomicron formation (1985) (2)
Short-term metabolic effects of recombinant human insulin-like growth factor I in the rat (1989) (2)
[On the theory of diabetes mellitus]. (1963) (2)
The effect of selective proximal vagotomy with and without pyloroplasty on serum gastrin levels and acid secretion after feeding and sham feeding in dogs (1977) (2)
[Primary stenosisn ("sclerosing") cholangitis. Contribution to the differential diagnosis of hepatic duct occlusion]. (1968) (2)
Acute metabolic actions of des-(B27–B30)-insulin and related analogues in adult rats (2004) (1)
Blood sugar lowering sulphonamide derivatives (1961) (1)
Effects of calcitonin gene related peptides (CGRP), Calcitonin (CT) and islet amyloid polypeptide (IAPP) on gastric motility of guinea pig and rat (1989) (1)
Pathobiology of the gastric mucosa. (1996) (1)
Hypoglycaemic effect of proinsulin and insulin in intact and eviscerated rats. (1988) (1)
Evaluation of a euglycemic clamp procedure as a diagnostic test for suspected autonomous hyperinsulinemia (1988) (1)
[Clinical significance of gastrointestinal hormones]. (1974) (1)
[Role of enzyme activation in the pathogenesis of pancreatitis]. (1969) (1)
Ornithine decarboxylase and polyamine biosynthesis in pancreatic adaptation. (1988) (1)
Serum levels of immunoreactive gastric inhibitory polypeptide and insulin in uraemic patients. (1977) (1)
[The importance of argyrophil and other pancreatic findings in diabetes mellitus and insuloma]. (1953) (1)
Pancreastatin: molecular and immunocytochemical characterization of a novel gastrointestinal peptide in porcine and human tissues (1988) (1)
[Acute kidney failure in pancreatitis]. (1967) (1)
[The causes of death in liver cirrhosis]. (1963) (1)
CCK-8, CCK-33, CCK-39 and CCK-58-characterization of their relative bioactivities and immunoreactivities (1992) (1)
Panel Discussion: Future Aspects of α-Glucosidase Inhibition (1988) (1)
Isolation and characterization of the new biologically active peptide VQY from porcine gut (1985) (1)
[Euthanasia: spiritual roots in the 19th, crime in the 20th, legalization in the 21st century?]. (2000) (1)
Inhibition of gastric acid and gastrin secretion by somatostatin in man. (1976) (1)
Role of the Enteroinsular Axis in Obesity (1980) (1)
[Findings in the remaining antrum after Billroth-II operations (excluded antrum)--a contribution to the differential diagnosis of recurrent ulcers with hypergastrinemia]. (1976) (1)
Effects of endogenous glucagon on the response of GIP, insulin and gastrin to oral glucose or fat (1980) (1)
Endocrinology of duodenal ulcer (1979) (1)
[Prognosis of transfusion hepatitis. Studies of 90 patients]. (1971) (1)
Pancreatic polypeptide response to sham feeding in man. (1984) (1)
VIP-receptor antagonist (N-Ac-Tyr1,D-Phe2)-GRF(1–29)-NH2 is a potent agonist for enzyme secretion in isolated rat pancreatic acini (1992) (1)
[Glucose tolerance & islet regeneration in partially pancreatectomized rats under ACTH & long term treatment with N-(4-methyl-benzolsulfonyl)-N'-butylurea]. (1958) (1)
[Gastrin and duodenal ulcer]. (1974) (1)
A New Editor for ‘Digestion’ in 1978 (1978) (1)
[Diabetes as a life fate for the patient and problem for clinical andtheoretical medicine]. (1966) (1)
[Are proton pump inhibitors safe?]. (1994) (1)
[Consensus conferences and guidelines in gastroenterology: an illusion]. (1999) (1)
[Exocrine pancreas insufficiency in primary sclerosing cholangitis]. (1987) (1)
[FUNCTIONAL DIAGNOSIS IN DISEASES OF THE EXOCRINE PANCREAS]. (1964) (1)
The effect of cyclosporin A on rat pancreatic B-cell: interaction with the calcium-antagonist diltiazem. (2009) (1)
Gastrin producing G-cells and somatostatin producing D-cells in different states of gastric acid secretion (1980) (1)
The International Diabetes Website (1999) (1)
Somatostatin in pancreatitis (1986) (1)
Subject Index, Vol. 43, 1991 (1991) (1)
[Relation of A-cells and B-cells in the islands of Langerhans in diabetics and non-diabetics]. (1957) (1)
Topographical relationship of the antral somatostatin cell: an immunoelectron microscopical study (1986) (1)
Effects of copper on the exocrine pancreas (1983) (1)
[Reciprocal relation between the liver and diabetic mellitus]. (1961) (1)
The rise of gastrointestinal endocrinology since 1970 and Jens F. Rehfeld and his group right in the middle of it (2001) (1)
Contents, Vol. 53, 1992 (2004) (1)
[The role of pancreatic diagnosis for the correct indication for pancreatic surgery]. (1967) (1)
Contents, Vol. 53, 1992 (2004) (1)
[On serum hepatitis prevention in neurosurgery. (On the paper of W. Creutzfeldt et al: "Frequency and prevention of transfusion hepatitis"]. (1967) (1)
Seventh Annual Meeting of the European Association for the Study Of Diabetes Southampton, England, September 15–17, 1971 Abstacts, Part 1 (1971) (1)
[Effect of selective proximal vagotomy with and without pyloroplasty upon basal and food stimulated serum immunoreactive gastrin in patients with duodenal ulcer. (author's transl)]. (1975) (1)
PLASMA CONCENTRATION OF CCK AND NT IN PATIENTS WITH CYSTIC FIBROSIS BEFORE AND AFTER KREON (1989) (0)
[Gout as a complication of adult glycogen storage disease]. (1969) (0)
[The effect of splenectomy on liver function in liver cirrhosis]. (1960) (0)
Antral gastrin-producin g G-cells andsomatostatin- producing D-cells indifferent states ofgastric acid secretion* (1982) (0)
Fourth Annual Meeting of the European Association for the study of diabetes (1968) (0)
Subject Index, Vol. 30, 1984 (1984) (0)
[Preliminary results of immunosuppressive therapy in chronic liver diseases]. (1968) (0)
Albert E. Renold (1923-1988). (1988) (0)
Micronodular endocrine cell hyperplasia in hypergastrinaemia: Evidence of morphological heterogeneity (1992) (0)
[Glucose tolerance test in 727 first-line relatives of elderly diabetics]. (1969) (0)
European Association for the study of Diabetes First Annual Meeting, Montecatini Terme, 20. IV.-22.IV. 1965 (1965) (0)
[Influence of vagus stimuli on serum gastrin concentrations in man]. (1972) (0)
[Inquiries on the etiology, pathogenesis, therapeutic successes and survival time in a random group of 560 patients with liver cirrhosis]. (1966) (0)
Role of sympathetic nervous system in rat gastric somatostatin and gastrin release (1983) (0)
Subject Index, Vol. 41, 1988 (1988) (0)
Gastrointestinal Hormones: 8th International Symposium, Timmendorfer Strand, Baltic Sea, September 1990: Abstracts (1990) (0)
Subject Index, Vol. 52, 1992 (1992) (0)
GIP and the metabolic response to carbohydrate and fat (1984) (0)
Contents, Vol. 48, 1991 (1991) (0)
Somatostatin therapy of acute experimental pancreatitis 715 and trypsin ( EC 3444 ) (2006) (0)
[Surgical therapy of chronic pancreatitis: the devil's advocate commentary]. (1987) (0)
[Azathioprine influence on liver cirrhosis in man and animal experiment]. (1973) (0)
Subject Index, Vol. 33, 1986 (1986) (0)
Subject Index, Vol. 46, Supplement 2, 1990 (1990) (0)
[Digoxin bioavailability under the effect of guar]. (1983) (0)
[Ismar Boas--laudatio]. (1992) (0)
[Serial biopsies in healthy carriers of hepatitis Bs antigen (author's transl)]. (1976) (0)
Effect of constant rate enteral nutrition on gastric inhibitory polypeptide (GIP) secretion in infants (1983) (0)
[Indications, results and complications of laparoscopic exploration (report on 1,580 cases)]. (1960) (0)
Organization section (2005) (0)
Subject Index, Vol. 46, Supplement 2, 1990 (1990) (0)
[Observations on 4 patients with total duodenopancreatoctomy for carcinoma of the pancreas]. (1963) (0)
[Histological functional diagnosis of the adrenal glands; studies on guinea pigs during swimming training and during fasting]. (1953) (0)
Further substances proved as oral anti-diabetic drugs (1961) (0)
Insulin-like growih factor II (IGF II) exerts acute metabolic actions on adult rat hepatocytes (1990) (0)
Book reviews (1981) (0)
continuous maintenance therapy with omeprazole for more than 10 years in patients with severe peptic ulcer or reflux esophagitis disease (13–17 years) (2001) (0)
[Clinical observations and experimental findings in the treatment of hyperinsulinism with diazoxide]. (1967) (0)
[Comparative experiments on the glycogen content in liver & diaphragm of rats after the administration of insulin & D 860]. (1957) (0)
[Letter: Ability to work in persistent hepatitis-B-antigen]. (1976) (0)
Influence of adrenal extirpation, adrenal cortex hormones and glucagon on the insulin-sensitivity of eviscerated rats (1962) (0)
[Effect of radioactive zinc on blood sugar and islands of Langerhans in rabbit]. (1953) (0)
[Endemia of Australia (SH) antigen-positive hepatitis in a dialysis center]. (1971) (0)
[Opening speech by the president of the German Society for Digestive and Metabolic Disorders; 32nd congress]. (1977) (0)
[Histologically diagnosed florid hepatitis six weeks before jaundice onset]. (1959) (0)
Omeprazole Tolerability (1994) (0)
[Medical ethics in the medical-industrial complex]. (1993) (0)
[Embryopathy caused by hepatitis viruses?]. (1973) (0)
Treatment of Chronic Salmonella Excreters by Injection of Antibiotics directly into the Gall-Bladder during Laparotomy. (1965) (0)
Experimentally Induced Endocrine Pancreatic Tumors in the Rat (1981) (0)
[Potentiation of the effects of exogenous insulin by N-(4-methylbenzenesulfonyl)-N'-butylurea and N1-n-butylbiguanide in the eviscerated animal]. (1961) (0)
[THE PROBLEM OF DIABETES: PREDIABETES, ABNORMAL MINIMUM AND ABNORMAL MAXIMUM INSULIN REQUIREMENTS, ORAL ANTIDIABETICS]. (1964) (0)
Ulcus ventriculi, Indikation zur Operation (1981) (0)
Reply to the Letter to the Editor of R. W. Ammann : Pain Profile in Alcoholic and Nonalcoholic Chronic Pancreatitis (CP) (1996) (0)
Isolation and partial sequence determination of porcine prosomatostatin and an N-s (1984) (0)
[Serum enzyme activities and bromsulfalein retention under the influence of ovulation inhibitors]. (1969) (0)
Subject Index, Vol. 53, 1992 (2004) (0)
[Behavior of alkaline phosphatase in A cells in rat after administration of D-860]. (1956) (0)
Subject Index, Vol. 53, 1992 (2004) (0)
[14C-aminopyrine-(pyramidone) respiratory test--a new quantitative liver function test]. (1976) (0)
[Australia-SH antigen isolation in patients with liver disease]. (1971) (0)
[Effect of N1-sulfanilyl-N2-butylcarbamide(carbutamide) on the metabolism of isolated, perfused livers of normal and alloxandiabetic, ketotic rats]. (1967) (0)
Cimetidine : proceedings of an International Symposium on Histamine H[2]-Receptor Antagonists, 10th-11th November, 1977, Göttingen, Federal Republic of Germany (1978) (0)
[On the preceding letter by K. Schmidt: "On serum hepatitis prevention in neurosurgery"]. (1967) (0)
[CLINICAL ASPECTS OF ACUTE AND CHRONIC PANCREATITIS]. (1963) (0)
[We hope that the responsible persons learn from the experience!]. (1995) (0)
Rise in serum-gastrin during insulin hypoglycaemia with and without simultaneous gastric aspiration. (1973) (0)
[Gastrointestinal endocrinology (author's transl)]. (1977) (0)
Introduction to the Clinical Papers (1990) (0)
[Studies on liver toxicity of obidoxim (Toxogonin) in humans]. (1970) (0)
Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction induced by secretin, cholecystokinin-pancreozymin and carbachol administration. (1976) (0)
[Controlled study on the effect of guar on ambulatory type II diabetics]. (1983) (0)
[Inhibition of gastric secretion by i.v. gastric inhibitory polypeptide (GIP) in man (author's transl)]. (1980) (0)
[Radical removal of the pancreas in man-indications, results, sequelae]. (1961) (0)
Contents, Vol. 35, Supplement 1, 1986 (1986) (0)
[ADH-like mechanism of action of chlorpropamide in diabetes insipidus (a comparison with the antidiuretic effect of other blood glucose decreasing sulfonamides and hydrochlorothiazide)]. (1970) (0)
[Relation of gastrin serum levels to the gastrin content and G-cells of antral mucosa in man]. (1971) (0)
[Pathogenesis of recurrent ulcer in the operated-on stomach]. (1977) (0)
[Phospholipase A--a probable decisive factor in the pathogenesis of acute pancreatitis]. (1967) (0)
[Hepatitis following blood transfusions]. (1971) (0)
[Experimental research on the mechanism of action of the hypoglycemic sulphamides]. (1957) (0)
Simultaneous immunosuppression and contraception (1970) (0)
Contents, Vol. 52, 1992 (1992) (0)
Book Reviews (1929) (0)
[Ability to work in Australia antigen persistence]. (1973) (0)
Exocrine and endocrine pancreatic functions in children with the short bowel syndrome. (1987) (0)
Somatostatin therapy ofacuteexperimental pancreatitis1 (1977) (0)
[Transluminal occlusion treatment of liver metastases of hormone-producing tumors]. (1983) (0)
Ulcus duodeni. Indikationen zur Operation (1981) (0)
JOURNAL COMMITTEE OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION (1972) (0)
Pfizer-Europe Travel Fellowships 1973 (2005) (0)
[Recurrent jaundice with fatal liver necrosis after halothane anesthesia performances]. (1967) (0)
[Infectious jaundice]. (1971) (0)
Subject Index, Vol. 51, Supplement 1, 1992 (1992) (0)
[Treatment of liver cirrhosis with glucocorticoids]. (1959) (0)
[Physiology and pathology of the entero-insular axis]. (1985) (0)
[Chronic aggressive hepatitis]. (1973) (0)
[Technique and use of percutaneous transhepatic cholangiography (PTC) with the CHIBA needle (author's transl)]. (1978) (0)
[Effect of long-term glucagon administration on the intestinal absorption of glucose, water and electrolytes]. (1974) (0)
Thank you to reviewers (2005) (0)
[Morphological changes of the pancreatic islets and their relations to carbohydrate metabolism; with special reference to peroral antidiabetic drugs]. (1956) (0)
Preservation of the porcine pancreas with HTK and Euro‐Collins solution: studies in a reperfusion system (1990) (0)
[Pancreatitis in primary hyperparathyroidism and calciphylaxis]. (1965) (0)
SMS 201–995 for treatment of patients with carcinoid tumors and Zollinger-Ellison-syndrome (1987) (0)
Nutrient Regulation of Insulin Secretion (1993) (0)
[Letter: Immunoglobulins in viral hepatitis]. (1974) (0)
[Studies on the metabolic effects of hypoglycemic biguanides in various animal species]. (1963) (0)
[Decrease in the occurrence of transfusion hepatitis in Göttingen hospitals following the introduction of routine transaminase and Australia antigen determination in blood donors]. (1971) (0)
[Zollinger-Ellison syndrome]. (1972) (0)
[RELATION BETWEEN GLUCOSE AND KETONE BODY METABOLISM IN EVISCERATED, NEPHRECTOMIZED RATS AND THE EFFECT OF OXALOACETATE, CITRATE AND PYRUVATE ON PERIPHERAL UPTAKE OF KETONE BODIES]. (1965) (0)
[Immunosuppression and simultaneous contraception]. (1970) (0)
Contents, Vol. 26, 1983 (1983) (0)
[Possible ACTH-like action of heparin on the adrenal cortex]. (1955) (0)
Thank You to Reviewers (1996) (0)
Editorial comment (1972) (0)
Acute and chronic effects of cyclosporine A on pancreatic polyamine metabolism and pancreatic adaptation. (1990) (0)
Histological tests of adrenal function. (Studies on the guineapig in swimming training and starvation.). (1953) (0)
[Factitious diarrhea in the differential diagnosis of chronic diarrhea. Observations on 7 patients]. (1989) (0)
[Do other proton pump blockers have advantages over Antra (omeprazole)?]. (1996) (0)
[Clinical research today and its promotion by industry--advantages and risks]. (1999) (0)
Influence of medium-chain triglycerides on steatorrhea--in maldigestion, malabsorption and primary exudative enteropathy. (1971) (0)
Contents, Vol. 41, 1988 (1988) (0)
シンポジアム (2) 内服糖尿病剤の諸問題 Wirkungsmechanismus der Sulfonylharnstoffe (1961) (0)
[ACTH-effect and heparin in thymus involution test]. (1954) (0)
[Experimental studies on the function of the A cells of the islands of Langerhans and on glucagon effect]. (1955) (0)
[Zollinger-Ellison syndrome]. (1969) (0)
Effect of oral ovulation inhibitors on normal clinical chemical levels (1969) (0)
[Preliminary report on the cooperative DFG study "Acute viral hepatitis"]. (1976) (0)
Digestive Function and Regulatory Gut Peptides with Special Reference to the Role of Cholecystokinin1 (1992) (0)
Discussion Practical Considerations Regarding Long-Term Treatment with Omeprazole (2004) (0)
[Letter: Transfusion hepatitis: incubation time and transition to chronic-aggressive course]. (1975) (0)
[CURING SALMONELLA CARRIERS BY DIRECT ANTIBIOTIC INJECTIONS INTO THE GALLBLADDER DURING LAPAROSCOPY]. (1965) (0)
[THE PROBLEMS OF THE NON-RECOGNIZED DUBIN-JOHNSON SYNDROME (CLINICAL AND BIOPSY FINDINGS COVERING A PERIOD OF 11 YEARS)]. (1964) (0)
Clinical value of dual-isotope fat absorption test system (FATS) using glycerol [125I]trioleate and glycerol [75Se]triether (1986) (0)
[What is the role of H2 receptor blockers today in ulcer therapy?]. (1996) (0)
[Fatty liver, glucose tolerance and tolbutamide test after drawing off pancreatic venous blood and portal blood from the liver]. (1966) (0)
Postersession IV: Gastroenterologie (1984) (0)
Guanidine and guanidine derivatives (1961) (0)
[Preliminary results of immunosuppressive treatment in chronic liver diseases]. (1968) (0)
Subject Index, Vol. 26, 1983 (1983) (0)
Trophic effect of tetragastrin on gastric and pancreatic secretion in the dog? (1980) (0)
Contents, Vol. 33, 1986 (1986) (0)
[Proceedings: Insulin, DNA, protein and enzyme concentrations of the pancreas and ciliated border enzymes following short-term and long-term feeding of an alpha-amylase-inhibitor (Bay e 4609)]. (1976) (0)
International Symposium on Experimental and New Therapeutic Approaches to Ulcer Disease (1985) (0)
International Symposium on Experimental and New Therapeutic Approaches to Ulcer Disease (1985) (0)
[Synthaline hypoglycemia, alpha cells and glucagon]. (1955) (0)
[On the differential diagnosis of transfusion hepatitis]. (1967) (0)
Discussion Acid-Related Diseases – New Perspectives (1992) (0)
Problems in treating pancreatitis with enzyme inhibitors. (1966) (0)
[Is the increase of hypoglycemic reactions during glibenclamide therapy due to a substance-specific stronger stimulation of the insulin secretion?]. (1971) (0)
Co-Workers of Nils Alwall Contributing to the Festschrift (1985) (0)
[Hepatotoxic effects of 2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy)propionic acid (Ciba 13,437-Su)]. (1972) (0)
Subject Index, Vol. 48, 1991 (1991) (0)
[Effect of cobaltous chloride on blood sugar and islands of Langerhans in rodents]. (1954) (0)
[Electrolyte secretion in a pancreatic duct model of the rat]. (1975) (0)
[IMPORTANCE OF TRANSAMINASE DETERMINATION FOR DIMINUTION OF THE RISK OF HEPATITIS IN BLOOD TRANSFUSION]. (1964) (0)
Uncontaminated pancreatic acinar cell fractions? (1977) (0)
[The syntropism of diabetes mellitus and obesity]. (1978) (0)
[Studies on uremic carbohydrate metabolism disorder]. (1968) (0)
[Oral diabetes therapy with sulfonamide derivatives]. (1956) (0)
Statement on ‘post-prandial’ or ‘reactive’ hypoglycemia (1987) (0)
[ON THE SIGNIFICANCE OF ACETOIN FOR THE PATHOGENESIS OF HEPATIC COMA. EXPERIMENTAL STUDIES]. (1964) (0)
Effect of synthetic "thyrotropin-releasing factor" on plasma levels of thyrotropin and growth hormone in healthy subjects and patients with hyperthyroidism or primary hypothyroidism. (1971) (0)
Eighth annual meeting of the European Association for the Study of Diabetes (1973) (0)
Natural Histories of Alcoholic and Idiopathic Chronic Pancreatitis (1996) (0)
[CLINICAL AND EXPERIMENTAL STUDIES ON INSULIN ALLERGY AND INSULIN RESISTANCE]. (1965) (0)
Book reviews (1983) (0)
[Diabetes and pregnancy]. (1967) (0)
Antibody determination prior to rubella immunization (1973) (0)
[The function of the A cells in liver injuries, stress and hypoglycemia]. (1954) (0)
[Studies on the vagal release of gastrin in patients with duodenal ulcer and in healthy individuals]. (1974) (0)
[Clinical and biopsy studies in blood donors with elevated serum transminases]. (1968) (0)
Contents, Vol. 30, 1982 (2004) (0)
Postprandial release of some enterohormones in children with chronic persistent hepatitis and posthepatitic cirrhosis. (1987) (0)
[Working ability in Australia antigen persistence]. (1971) (0)
[RADICAL, PALLIATIVE OR CONSERVATIVE TREATMENT OF PANCREATIC CARCINOMA?ON THE EVALUATION OF 150 CASES]. (1963) (0)
The Entero-insular axis : satellite symposium to the 10th IDF-Meeting, Göttingen, September 7-8, 1979 (1980) (0)
Metabolic activity of insulin-like growth factor I on cultured rat liver parenchymal cells (1989) (0)
[Results of surgical treatment in chronic pancreatitis]. (1974) (0)
[Diabetes & synthetic antidiabetics]. (1958) (0)
Title Page / Contents / Foreword (1980) (0)
[The effect of N1, n-butylbiguanide on the metabolism of isolated perfused livers of normal and alloxan-diabetic ketotic rats]. (1967) (0)
[Effect of D 860 & diabetogenic hormone on the beta cell system in normal & hypophysectomized rats & rabbits]. (1957) (0)
Insulin and liver disease: effect of proinsulin on hepatic carbohydrate metabolism (1985) (0)
Mechanism of insulin resistance in cirrhotic rats (1990) (0)
OMEPRAZOLE TOLERABILITY. AUTHOR'S REPLY (1994) (0)
[The influence of splenectomy on liver function in liver cirrhoses]. (1960) (0)
[Oral diabetes therapy and its experimental principles]. (1960) (0)
Adrenergic modulation of rat gastric D-cell (1980) (0)
[Inhibition of the intestinal transport of amino acids and calcium through blood sugar reducing biguanides]. (1971) (0)
Contents, Vol. 43, 1991 (1991) (0)
[IN VITRO STUDIES ON THE PANCREATIC ISLANDS OF THE RAT]. (1964) (0)
[Serum lipids in 1st-grade relatives of diabetics in relation to body weight and glucose tolerance]. (1969) (0)
Book reviews (2011) (0)
9 Calciphylactic Pancreatitis and Pancreatitis in Hyperparathyroidism (1970) (0)
Blood sugar lowering substances without clinical significance (1961) (0)
[INTRAPANCREATIC ACTIVATION OF PROTEOLYTIC ENZYMES AND THE EFFECT OF TRASYLOL IN EXPERIMENTAL PANCREATITIS IN RATS]. (1963) (0)

This paper list is powered by the following services:

Other Resources About Werner Creutzfeldt

en.wikipedia.org

What Schools Are Affiliated With Werner Creutzfeldt?

Werner Creutzfeldt is affiliated with the following schools:

Image Attributions

Image Source for Werner Creutzfeldt